Ensysce Biosciences Inc (ENSC) — Cash Flow Reinvestment Rate
Ensysce Biosciences Inc (ENSC) has a Cash Flow Reinvestment Rate of 0.99x as of March 2020, reinvesting $134.62 Million (capex $4.00 plus investments $134.62 Million) from operating cash flow of $136.09 Million. Explore ENSC capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Ensysce Biosciences Inc Cash Flow Reinvestment Rate (2019–2019)
Historical reinvestment intensity for Ensysce Biosciences Inc across 1 annual periods. Also explore Ensysce Biosciences Inc total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Ensysce Biosciences Inc (2019–2019)
Year-by-year capital reinvestment analysis for Ensysce Biosciences Inc. For live market cap and broader valuation context, see market cap of Ensysce Biosciences Inc.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2019 | 1.08x | $11.85 Million | $10.99 Million | $4.00 | — |